Get the Stockscreener App
0.7206
3.55%
0.0247
After Hours:
.74
0.0194
+2.69%
Hyperfine Inc stock is traded at $0.7206, with a volume of 121.79K.
It is up +3.55% in the last 24 hours and down -12.12% over the past month.
Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. The company derives its revenue from sale of sales of MRI devices and service sales which consist of sales from subscriptions of bundled devices, maintenance, and software.
See More
Previous Close:
$0.6959
Open:
$0.69
24h Volume:
121.79K
Relative Volume:
0.11
Market Cap:
$54.43M
Revenue:
$11.03M
Net Income/Loss:
$-44.24M
P/E Ratio:
-1.1623
EPS:
-0.62
Net Cash Flow:
$-42.61M
1W Performance:
+3.05%
1M Performance:
-12.12%
6M Performance:
-27.21%
1Y Performance:
-15.22%
1-Day Range:
$0.69
$0.737
1-Week Range:
$0.6686
$0.737
52-Week Range:
$0.5837
$1.90
Hyperfine Inc Stock (HYPR) Company Profile
Name
Hyperfine Inc
Sector
Industry
Phone
866-796-6767
Address
351 NEW WHITFIELD STREET, GUILFORD
Compare HYPR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HYPR
Hyperfine Inc
|
0.7206 | 54.43M | 11.03M | -44.24M | -42.61M | -0.62 |
|
ABT
Abbott Laboratories
|
131.73 | 218.91B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
95.05 | 139.37B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
348.12 | 134.90B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
83.37 | 106.90B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
70.60 | 41.45B | 5.72B | 4.17B | 259.90M | 6.97 |
Hyperfine Inc Stock (HYPR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-11-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| May-31-22 | Initiated | Evercore ISI | Outperform |
| Apr-14-22 | Initiated | Wells Fargo | Overweight |
Hyperfine Inc Stock (HYPR) Latest News
Hyperfine Enrolls Initial Patients in NEURO PMR Study to Evaluate Use of AI-Powered Portable MRI in Neurology Offices - 01net
Hyperfine Enrolls First Patients in Portable MRI Evaluation Study - marketscreener.com
Hyperfine enrolls initial patients in NEURO PMR study - TipRanks
Revolutionary Portable MRI Secures Medicare Coverage as Major Clinical Trial Launches - Stock Titan
HYPR Stock Price and Chart — NASDAQ:HYPR - TradingView
HYPR stock touches 52-week low at $0.76 amid market challenges - Investing.com
Lake Street Initiates Coverage of Hyperfine (HYPR) with Buy Recommendation - MSN
Lake Street starts Hyperfine stock with Buy, sets $1.50 target By Investing.com - Investing.com Australia
Lake Street starts Hyperfine stock with Buy, sets $1.50 target - Investing.com
Lake Street Initiates Hyperfine at Buy With $1.50 Price Target -March 24, 2025 at 08:20 am EDT - MarketScreener
Hyperfine initiated with a Buy at Lake Street - TipRanks
What You Can Learn From Hyperfine, Inc.'s (NASDAQ:HYPR) P/S After Its 28% Share Price Crash - Simply Wall St
Hyperfine price target lowered to $1.20 from $1.50 at B. Riley - TipRanks
B. Riley Trims Price Target on Hyperfine to $1.20 From $1.50, Keeps Buy Rating -March 20, 2025 at 07:57 am EDT - Marketscreener.com
Hyperfine, Inc. (NASDAQ:HYPR) Q4 2024 Earnings Call Transcript - Insider Monkey
Hyperfine Inc. Faces Potential Stock Price Decline Amid $150 Million Securities Sale Plan - TipRanks
Hyperfine Inc. Earnings Call: Growth Amid Challenges - TipRanks
Jefferies lifts Hyperfine stock price target to $1.20, keeps Hold rating By Investing.com - Investing.com South Africa
Jefferies lifts Hyperfine stock price target to $1.20, keeps Hold rating - Investing.com
HYPR Stock Jumps on NVIDIA Partnership to Advance AI Neuroimaging - Nasdaq
Hyperfine teams up with NVIDIA to enhance AI-powered portable MR - DOTmed HealthCare Business News
Hyperfine reports net loss of USD 10.39M in Q4 2024 - Medical Buyer
Hyperfine Inc (HYPR) Q4 2024 Earnings Call Highlights: Navigating Growth and Challenges By GuruFocus - Investing.com Canada
NVIDIA partners with Hyperfine on Swoop MRI AI system - MSN
Earnings call transcript: Hyperfine Q4 2024 reports mixed results By Investing.com - Investing.com Australia
Hyperfine, Inc. Reports 2024 Financial Results and Strategic Expansion - TipRanks
Earnings call transcript: Hyperfine Q4 2024 reports mixed results - Investing.com India
Hyperfine earnings matched, revenue fell short of estimates - Investing.com
Hyperfine Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Hyperfine shares tumble as Q4 revenue misses estimates By Investing.com - Investing.com South Africa
Hyperfine shares tumble as Q4 revenue misses estimates - Investing.com
HYPERFINE Earnings Results: $HYPR Reports Quarterly Earnings - Nasdaq
Hyperfine, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results - The Manila Times
Hyperfine reports Q4 EPS (14c), consensus (14c) - TipRanks
Hyperfine, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Business Update - Nasdaq
Hyperfine, Nvidia Partner To Make Brain MRIs More Affordable - Benzinga
Hyperfine and NVIDIA Collaborate to Revolutionize Neuroimaging with AI-Powered Innovation - 01net
Hyperfine, NVIDIA Partner to Transform Neuroimaging with AI - Medical Product Outsourcing
Hyperfine Collaborating With Nvidia to Improve Portable MRI Technology; Shares Jump - Marketscreener.com
Hyperfine partners with NVIDIA to enhance portable MRI tech - Investing.com India
Hyperfine partners with NVIDIA to enhance portable MRI tech By Investing.com - Investing.com Australia
Earnings Scheduled For March 17, 2025 - Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
HYPERFINE Earnings Preview: Recent $HYPR Insider Trading, Hedge Fund Activity, and More - Nasdaq
Hyperfine (HYPR) Projected to Post Earnings on Monday - Defense World
When Will Portable MRI Pioneer Hyperfine Reveal Its 2024 Performance? - StockTitan
Hyperfine, Inc. to Announce Fourth Quarter and Full Year 2024 Financial Results on March 17, 2025 - Business Wire
Insider Selling: TEISSEYRE THOMAS, Hyperfine Inc [HYPR] Chief Operating Officer divested 3,237 shares - Knox Daily
Hyperfine COO Thomas Teisseyre sells $3,884 in stock By Investing.com - Investing.com Australia
Hyperfine COO Thomas Teisseyre sells $3,884 in stock - Investing.com India
Hyperfine reports growing evidence supporting use of Swoop system images in stroke diagnosis - NeuroNews International
Hyperfine Inc Stock (HYPR) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.32%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):